Genus PLC
F:GBE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genus PLC
F:GBE
|
UK |
|
O
|
Obayashi Corp
F:OBA
|
JP |
|
Corero Network Security PLC
F:NYA1
|
UK |
|
Strongpoint ASA
LSE:0JEZ
|
NO |
|
M
|
Molten Ventures PLC
OTC:GRWXF
|
UK |
|
S
|
SanDisk Corp
DUS:BW9
|
US |
|
Cannabist Company Holdings Inc
F:VW5
|
US |
Genus PLC
Genus PLC is an animal genetics company. It develops and licenses breeding stock and genetic material for livestock, especially pigs and cattle. Its products help farmers and meat and dairy producers raise animals with better growth, health, fertility, and feed efficiency. The company sells semen, breeding animals, and genetic services, and it earns money from selling these products and from royalties or licensing fees tied to its proprietary genetics. Its customers are livestock producers, breeding companies, and other food supply chain businesses that want better animals for their herds and breeding programs. Genus sits near the start of the livestock value chain. Instead of producing meat or milk itself, it supplies the genetic building blocks that shape future herds. That makes its business different from a typical farm supplier: its value comes from long-term breeding programs, data, and intellectual property rather than physical commodities.
Genus PLC is an animal genetics company. It develops and licenses breeding stock and genetic material for livestock, especially pigs and cattle. Its products help farmers and meat and dairy producers raise animals with better growth, health, fertility, and feed efficiency.
The company sells semen, breeding animals, and genetic services, and it earns money from selling these products and from royalties or licensing fees tied to its proprietary genetics. Its customers are livestock producers, breeding companies, and other food supply chain businesses that want better animals for their herds and breeding programs.
Genus sits near the start of the livestock value chain. Instead of producing meat or milk itself, it supplies the genetic building blocks that shape future herds. That makes its business different from a typical farm supplier: its value comes from long-term breeding programs, data, and intellectual property rather than physical commodities.
Record Profit: Genus delivered record first-half profit, with PBT up 57% to GBP 55.7 million and EPS up 53% to 60.8p, driven by growth in PIC and benefits from ABS' Value Acceleration Programme.
Strong Cash Flow: Free cash flow remained strong at GBP 8.2 million, close to last year’s record, with expectations to exceed FY '25's record level for the full year.
PIC China Growth: PIC China achieved over 50% royalty revenue growth, winning around 25 new customers over two years and forming a major joint venture with BCA.
ABS Margin Expansion: ABS saw profit rise 27%, with margin up 180 bps to 7.1%, propelled by VAP initiatives, and continues to target a double-digit margin.
PRP Progress: Regulatory progress on PRRS Resistant Pig (PRP) continues, including a key approval in Canada, with rising investment in market acceptance activities.
Guidance Reaffirmed: Management expects significant adjusted PBT growth for FY '26, in line with market expectations raised in January.
